Efficacy of Cadonilimab and Anlotinib Combination in Treating Multiple Drug-Resistant Pulmonary Large Cell Neuroendocrine Carcinoma: Insights from a Case Report and Literature Review
Release date:
2024-07-29
Description:
This study assesses the efficacy of different treatment approaches, such as the use of cadonilimab and anlotinib, by monitoring the patient's response through various cycles of treatment. This includes the use of computed tomography scans to evaluate treatment response. We believe that our study makes a significant contribution to the literature because the case report explores alternative treatment options for pulmonary large cell neuroendocrine carcinoma patients who have shown resistance to traditional programmed death 1 monoclonal antibodies and multiple chemotherapies. The use of cadonilimab and anlotinib in this context is highlighted, suggesting that this combination could be a potential treatment strategy.
For each controlled access study, there is a corresponding Data Access Committee(DAC) to determine the access permissions. Access to actual data files is not managed by NGDC.
You need to install the Aspera Connect plugin before uploading your files. If you dont have Aspera Connect plugin installed in your computer, please Download Aspera Connectand install it first.
[path/to/ascp]: Microsoft Windows: C:\Program Files\Aspera\Aspera Connect\bin\ascp.exe or
c:\users\[username]\AppData\Local\Programs\Aspera\Aspera Connect\bin\ascp.exe
Mac OS X: /Applications/Aspera/Connect.app/Contents/Resources/ascp (for admin's installation) or
/Users/[username]/Applications/Aspera/Connect.app/Contents/Resources/ascp (for non-admin's installation)
Linux: /opt/aspera/bin/ascp or
/home/[username]/aspera/connect/bin/ascp
[path/to/key/file] must be an absolute path, e.g.: /home/keys/aspera.openssh
[path/to/folder/containing/files] needs to specify the local folder that contains all the files to upload.
HRA008073.xlsx